Mercer Global Advisors
SCPH

Mercer Global Advisors’s scPharmaceuticals SCPH Stock Holding History

Mercer Global Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,006
Closed -$96.4K – 2955
2025
Q3 		$96.4K Buy
+17,006
New +$87.1K ﹤0.01% 2521

Mercer Global Advisors's SCPH Position: Q4 2025 in Review

Mercer Global Advisors sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 17,006 shares — an estimated $96.4K sold.

Mercer Global Advisors first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $96.4K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • Mercer Global Advisors reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Mercer Global Advisors sold 17,006 scPharmaceuticals shares in Q4 2025, an estimated $96.4K.
  • Mercer Global Advisors first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Mercer Global Advisors's scPharmaceuticals position peaked at $96.4K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Mercer Global Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.